Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
cancer
Pleco Therapeutics Announces Positive Outcome of Pre-IND meeting with FDA for PTX-252 in Acute Myeloid Leukaemia
26 mars 2025 03h00 HE
|
Pleco Therapeutics B.V.
Pleco Therapeutics announces positive FDA feedback on PTX-252, supporting IND pathway for its novel AML treatment.
ImCheck to Present Updated ICT01 Data with Unprecedented High Rates of Complete Remission in AML at the AACR Annual Meeting 2025
25 mars 2025 17h06 HE
|
ImCheck Therapeutics SAS
Marseille, France, March 25, 2025 4:30 p.m. EST/21:30 CET– ImCheck Therapeutics announced today it will present updated results from its ongoing open-label, randomized Phase I/II study EVICTION at the...
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025
25 mars 2025 16h30 HE
|
Abpro Corporation
WOBURN, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and...
Rakovina Therapeutics Unveils Preclinical Data at the AACR - World’s Premier Cancer Research Forum
25 mars 2025 16h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through...
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
24 mars 2025 08h00 HE
|
CG Oncology Inc.
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
Immuneering Corporation Announces Grant of Inducement Award
21 mars 2025 16h30 HE
|
Immuneering Corporation
Immuneering Corporation Announces Grant of Inducement Award
Allsup Supports Cancer And Careers’ Free Virtual Midwest Conference On Friday, March 28, 2025
21 mars 2025 12h49 HE
|
Allsup
Belleville, Illinois, March 21, 2025 (GLOBE NEWSWIRE) -- Allsup, the nation’s leading provider of Social Security Disability Insurance (SSDI) representation services, return-to-work support, and...
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
20 mars 2025 16h05 HE
|
Immuneering Corporation
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
20 mars 2025 07h30 HE
|
Plus Therapeutics Inc.
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
Oncology Small Molecule Drugs Market is Expected to Expand at 5.9% CAGR, Reaching USD 167,635 Million by 2035 | Fact.MR Report
20 mars 2025 06h00 HE
|
FACT.MR
Rockville, MD , March 20, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global oncology small molecule drugs market is estimated to...